Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.

作者: Yu Jia , Nian Gong , Teng-Fei Li , Bin Zhu , Yong-Xiang Wang

DOI: 10.1016/J.PHRS.2015.10.008

关键词:

摘要: Both peptidic agonist exenatide and herbal catalpol of the glucagon-like peptide-1 receptor (GLP-1R) are neuroprotective. We have previously shown that activation spinal GLP-1Rs expresses β-endorphin in microglia to produce antinociception. The aim this study was explore whether exert neuroprotection via hippocampal GLP-1R/β-endorphin pathway. rat middle cerebral artery occlusion model employed, GLP-1R immunofluorescence staining measurement were assayed hippocampus primary cultures microglia, neurons astrocytes. immunoreactivity on upregulated after ischemia reperfusion. Intracerebroventricular (i.c.v.) injection produced transient ischemia/reperfusion model, reflected by a marked reduction brain infarction size mild recovery neurobehavioral deficits. In addition, i.c.v. significantly stimulated expression cultured (but not or astrocytes). Furthermore, completely blocked orthosteric antagonist exendin (9-39), specific antiserum, selective opioid naloxone. Our results indicate, for first time, neuroprotective effects GLP-1R-specific, these mediated probably microglia. postulate contrast peripheral tissue, where pancreas islet β-cells causes secretion insulin perform glucoregulation, it leads microglial cells analgesia central nervous system.

参考文章(57)
Hui Fan, Nian Gong, Teng-Fei Li, Ai-Niu Ma, Xiao-Yan Wu, Ming-Wei Wang, Yong-Xiang Wang, The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia. British Journal of Pharmacology. ,vol. 172, pp. 64- 79 ,(2015) , 10.1111/BPH.12895
D J Drucker, S Asa, Glucagon gene expression in vertebrate brain. Journal of Biological Chemistry. ,vol. 263, pp. 13475- 13478 ,(1988) , 10.1016/S0021-9258(18)68261-4
Nian Gong, Ai‐Niu Ma, Li‐Jie Zhang, Xiao‐Su Luo, Yin‐Hui Zhang, Michael Xu, Yong‐Xiang Wang, Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity. British Journal of Pharmacology. ,vol. 163, pp. 399- 412 ,(2011) , 10.1111/J.1476-5381.2011.01227.X
Alexander Harkavyi, Peter S. Whitton, Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection British Journal of Pharmacology. ,vol. 159, pp. 495- 501 ,(2010) , 10.1111/J.1476-5381.2009.00486.X
Bingyang Xue, Bo Ma, Qi Zhang, Xiaotian Li, Jianwei Zhu, Ming Liu, Xiujuan Wu, Chao Wang, Zimei Wu, Pharmacokinetics and tissue distribution of Aucubin, Ajugol and Catalpol in rats using a validated simultaneous LC–ESI-MS/MS assay Journal of Chromatography B. ,vol. 1002, pp. 245- 253 ,(2015) , 10.1016/J.JCHROMB.2015.08.026
W. E. Schmidt, E. G. Siegel, W. Creutzfeldt, Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia. ,vol. 28, pp. 704- 707 ,(1985) , 10.1007/BF00291980
David G. Parkes, Richard Pittner, Carolyn Jodka, Pam Smith, Andrew Young, Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism-clinical and Experimental. ,vol. 50, pp. 583- 589 ,(2001) , 10.1053/META.2001.22519
María L. Villanueva-Peñacarrillo, Elena Delgado, David Vicent, Elena Mérida, Ana I. Alcántara, Isabel Valverde, GLP-1(7–36)amide binding in skeletal muscle membranes from streptozotocin diabetic rats Endocrine. ,vol. 3, pp. 685- 687 ,(1995) , 10.1007/BF02746345
TracyAnn Perry, Debomoy K. Lahiri, Kumar Sambamurti, Demao Chen, Mark P. Mattson, Josephine M. Egan, Nigel H. Greig, Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron Journal of Neuroscience Research. ,vol. 72, pp. 603- 612 ,(2003) , 10.1002/JNR.10611